Use of PDE4 inhibitors for the treatment of diabetes mellitus
View Patent ↗The invention relates to the use of certain known PIDE4 inhibitors for the treatment of diabetes mellitus and accompanying disorders thereof.
1. A method for treating diabetes mellitus type 2 in a patient, comprising administering to a patient in need thereof an effective amount of N-(3,5-Dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide.
2. The method of claim 1 , wherein administering comprises administering the N-(3,5-Dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide in a dosage form selected from the group consisting of an oral dosage form; an injectable dosage form; and an infusible dosage form.
3. The method of claim 2 , wherein the dosage form comprises an oral dosage form.
4. The method of claim 2 , wherein the dosage form comprises an injectable or an infusible dosage form.
5. A method for treating diabetes mellitus type 2 in a patient, comprising administering to a patient in need thereof an effective amount of a compound selected from the group consisting of N-(3,5-Dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide; a pharmaceutically acceptable salt thereof; an N-oxide thereof; and a pharmaceutically acceptable salt of an N-oxide thereof.
6. The method of claim 5 , wherein said administering comprises administering the compound in a dosage form selected from the group consisting of an oral dosage form; an injectable dosage form; and an infusible dosage form.
7. The method of claim 6 , wherein the dosage form comprises an oral dosage form.
8. The method of claim 6 , wherein the dosage form comprises an injectable or an infusible dosage form.